Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2002

01-08-2002

Angiotensin-(1–7) in normal and preeclamptic pregnancy

Authors: David C. Merrill, Michael Karoly, Kai Chen, Carlos M. Ferrario, K. Bridget Brosnihan, Ph.D.

Published in: Endocrine | Issue 3/2002

Login to get access
Metadata
Title
Angiotensin-(1–7) in normal and preeclamptic pregnancy
Authors
David C. Merrill
Michael Karoly
Kai Chen
Carlos M. Ferrario
K. Bridget Brosnihan, Ph.D.
Publication date
01-08-2002
Publisher
Humana Press
Published in
Endocrine / Issue 3/2002
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:18:3:239

Other articles of this Issue 3/2002

Endocrine 3/2002 Go to the issue

OriginalPaper

Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic cushing’s syndrome

OriginalPaper

Dexamethasone and adrenocorticotropin suppress prolactin secretion in humans

OriginalPaper

Structural aspects of luteinizing hormone receptor

OriginalPaper

Gingival enlargement in acromegaly

OriginalPaper

Apoptosis is developmentally regulated in rat growth plate

OriginalPaper

Gap junctional intercellular communication of bovine granulosa and thecal cells from antral follicles: Effects of luteinizing hormone and follicle-stimulating hormone
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits